Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
Ejhaem|August 21, 2023
Real-world complication burden and disease management paradigms in transfusion-related β-thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross-sectional studyAntonis Kattamis, Ersi Voskaridou, Sophia Delicou, et al.
European Journal of Haematology|March 20, 2026
Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND TrialKhaled M Musallam, Maria Domenica Cappellini, Antonis Kattamis, et al.
BMJ Open|March 22, 2023
Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemiaAli T Taher, Khaled M Musallam, Vip Viprakasit, et al.
American Journal of Hematology|November 6, 2018
Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© )Ali Taher, Vip Viprakasit, Maria Domenica Cappellini, et al.
BMJ Open|November 14, 2024
Identifying thresholds for meaningful improvements in NTDT-PRO scores to support conclusions about treatment benefit in clinical studies of patients with non-transfusion-dependent beta-thalassaemia: analysis of pooled data from a phase 2, double-blind, placebo-controlled, randomised trialAli T Taher, Khaled M Musallam, Vip Viprakasit, et al.
Human Mutation|March 17, 2010
Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA)Luigia De Falco, Francesca Totaro, Antonella Nai, et al.
Blood Advances|June 4, 2026
Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermediaAli Taher, Michael D Diamantidis, Antonis Kattamis, et al.
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A NetworkVincenzo De Sanctis, Ashraf Soliman, Ploutarchos Tzoulis, et al.
Blood|June 2, 2011
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-upM Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.
Blood Cells, Molecules & Diseases|August 17, 2011
Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trialsAurelio Maggio, Aldo Filosa, Angela Vitrano, et al.
Pageof 17